Clinical Trial Update: Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 1/2 study of topotecan in combination with carboplatin for relapsed ovarian cancer, with the trial compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Topotecan (topotecan)

Snippet

Sponsor: North Eastern German Society of Gynaecological Oncology | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-02-06